Belite Bio (BLTE) Stock
Belite Bio (BLTE) closed at $164.36 on Nov 13, 2026; its Tenet Score is 68 of 100 against 409 Healthcare peers.
32 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $164.36
- Nov 13, 2026
- Market cap
- $6.5Bunverified basis
- share basis not confirmed
- 52-week range
- 105.88 – 200.00
- low → high
- Tenet Score
- 68/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Belite Bio Inc scores 68/100. Solid. Strongest on financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 68 is built from 2 of 4 pillars, from 15% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Value & Growth omitted — no data yet.
Price
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
- ✕ Quality Floor
- ~ Qualified Dip
Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its…
Common questions
What sector and industry is Belite Bio in?
Belite Bio is in the Healthcare sector and the Drugs industry.
What is Belite Bio's Tenet Score?
Belite Bio's Tenet Score is 68 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




